BRPI0415043A - associação de um antiaterotrombótico e de um antiagregante plaquetário - Google Patents

associação de um antiaterotrombótico e de um antiagregante plaquetário

Info

Publication number
BRPI0415043A
BRPI0415043A BRPI0415043-0A BRPI0415043A BRPI0415043A BR PI0415043 A BRPI0415043 A BR PI0415043A BR PI0415043 A BRPI0415043 A BR PI0415043A BR PI0415043 A BRPI0415043 A BR PI0415043A
Authority
BR
Brazil
Prior art keywords
antiatherothrombotic
combination
antiplatelet agent
antiplatelet
agent
Prior art date
Application number
BRPI0415043-0A
Other languages
English (en)
Inventor
Laure Cloarec-Blanchard
Stefano Corda
Laurence Lerond
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0415043A publication Critical patent/BRPI0415043A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"ASSOCIAçãO DE UM ANTIATEROTROMBóTICO E DE UM ANTIAGREGANTE PLAQUETáRIO". A presente invenção refere-se a uma nova associação de um antiaterotrombótico e de um antiagregante plaquetário.
BRPI0415043-0A 2003-10-03 2004-10-01 associação de um antiaterotrombótico e de um antiagregante plaquetário BRPI0415043A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311595A FR2860436B1 (fr) 2003-10-03 2003-10-03 Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire
PCT/FR2004/002489 WO2005032533A1 (fr) 2003-10-03 2004-10-01 Nouvelle association d'un anti-atherothrombotique et d’un antiagregant plaquettaire

Publications (1)

Publication Number Publication Date
BRPI0415043A true BRPI0415043A (pt) 2006-12-12

Family

ID=34307392

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415043-0A BRPI0415043A (pt) 2003-10-03 2004-10-01 associação de um antiaterotrombótico e de um antiagregante plaquetário

Country Status (29)

Country Link
US (2) US20070054934A1 (pt)
EP (1) EP1677779B1 (pt)
JP (1) JP2007507475A (pt)
KR (1) KR100782246B1 (pt)
CN (1) CN100453075C (pt)
AR (1) AR046043A1 (pt)
AT (1) ATE409033T1 (pt)
AU (1) AU2004277734B2 (pt)
BR (1) BRPI0415043A (pt)
CA (1) CA2540062A1 (pt)
CY (1) CY1108388T1 (pt)
DE (1) DE602004016762D1 (pt)
DK (1) DK1677779T3 (pt)
EA (1) EA009418B1 (pt)
ES (1) ES2314457T3 (pt)
FR (1) FR2860436B1 (pt)
GE (1) GEP20084546B (pt)
HK (1) HK1093900A1 (pt)
HR (1) HRP20080546T3 (pt)
MA (1) MA28081A1 (pt)
MX (1) MXPA06003713A (pt)
MY (1) MY137953A (pt)
NO (1) NO20061944L (pt)
NZ (1) NZ545988A (pt)
PL (1) PL1677779T3 (pt)
PT (1) PT1677779E (pt)
SI (1) SI1677779T1 (pt)
UA (1) UA80220C2 (pt)
WO (1) WO2005032533A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05014086A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias antiagregantes plaquetarios combinadas para su uso en el tratamiento y prevencion de eventos vasculares de origen isquemico.
FR2899473B1 (fr) * 2006-04-07 2008-06-13 Servier Lab Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires
WO2008127682A2 (en) * 2007-04-13 2008-10-23 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6509348B1 (en) * 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination

Also Published As

Publication number Publication date
MXPA06003713A (es) 2006-06-14
AR046043A1 (es) 2005-11-23
EA200600657A1 (ru) 2006-08-25
CN100453075C (zh) 2009-01-21
CA2540062A1 (fr) 2005-04-14
GEP20084546B (en) 2008-11-25
JP2007507475A (ja) 2007-03-29
HRP20080546T3 (en) 2009-01-31
ATE409033T1 (de) 2008-10-15
DK1677779T3 (da) 2009-01-05
EA009418B1 (ru) 2007-12-28
DE602004016762D1 (de) 2008-11-06
US20070054934A1 (en) 2007-03-08
CY1108388T1 (el) 2014-02-12
UA80220C2 (en) 2007-08-27
NO20061944L (no) 2006-05-02
MA28081A1 (fr) 2006-08-01
MY137953A (en) 2009-04-30
KR100782246B1 (ko) 2007-12-05
AU2004277734B8 (en) 2005-04-14
EP1677779B1 (fr) 2008-09-24
FR2860436A1 (fr) 2005-04-08
HK1093900A1 (en) 2007-03-16
KR20060061399A (ko) 2006-06-07
SI1677779T1 (sl) 2009-02-28
FR2860436B1 (fr) 2006-01-20
AU2004277734B2 (en) 2007-05-24
PL1677779T3 (pl) 2009-02-27
EP1677779A1 (fr) 2006-07-12
PT1677779E (pt) 2008-10-23
WO2005032533A1 (fr) 2005-04-14
ES2314457T3 (es) 2009-03-16
NZ545988A (en) 2008-11-28
CN1859902A (zh) 2006-11-08
US20100056564A1 (en) 2010-03-04
AU2004277734A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
RS52843B (en) THE NEW IS THE HYDROGEN SULPHATE
BR0213981A (pt) Fotoiniciadores difuncionais
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
CY1105575T1 (el) Ενωσεις αμιδιου και χρηση αυτων
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
RS52784B (en) They're TANATE RAZAGILINA
FR2844203B1 (fr) Parfumeur d'ambiance
DE60106954D1 (de) Resorcin-derivate
DE602004031372D1 (de) Nachweis von staphylococcus
MA29154B1 (fr) Promedicament amide de gemcitabine, compositions et utilisations associees
DE60122577D1 (de) Zweikomponenten zahnpasta zur unterdrückung von mundgeruch
DE60332646D1 (de) Prolinderivate mit affinität für die alpha-2-delta untereinheit des calciumkanals
WO2007022321A3 (en) Substituted indoles and use thereof
BR0312996A (pt) Sal de (s)-pantoprazol e seus hidratos
BRPI0415043A (pt) associação de um antiaterotrombótico e de um antiagregante plaquetário
DE60326190D1 (de) des Körpers
DE50205129D1 (de) 8-tetradecenal als duft- oder aromastoff
BR0102764A (pt) Composições de borracha contendo um complexo de composto de fósforo trivalente-sìlica
NO20024880L (no) Sammensetning inneholdende fosfat
HN2002000335A (es) Compuestos asapoliciclicos condensados con arilo
BR0116646B1 (pt) aperfeiÇoamento da integridade de emplastro pela substituiÇço do adesivo construtivo com compressÕes ultrassânicas.
ATE367939T1 (de) Verdampferanordnung
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
DE50207869D1 (de) Metallorganisches antitumormittel
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.